Axogen, Inc. specializes in the science and development of biologic and engineered products for peripheral nerve repair. The company's core portfolio includes the Avance Nerve Graft, a decellularized human nerve allograft used to bridge nerve gaps, as well as the Axoguard Nerve Connector, Axoguard Nerve Protector, and Avive+ Soft Tissue Matrix. These products serve as advanced alternatives to traditional nerve autografts, addressing a wide range of traumatic and iatrogenic nerve injuries. Operating primarily in the United States with a growing international presence in Canada and parts of Europe, Axogen targets the trauma, oral maxillofacial, breast reconstruction neurotization, and upper extremity compression markets. By focusing exclusively on regenerative medicine and surgical nerve reconstruction, the company has established a leading competitive position in the peripheral nerve repair market.
